Chronic complication risk and benefits of fenofibrate in type 2 diabetes by a PPARα polymorphism (rs6008845, C/T): a FIELD trial substudy. - Januszewski AS; Huang MLH; Mangani AS; Ong KL; Dalton C; O'Connell RL; Li L; Sullivan DR; Strbenac D; Donoghoe MW; Brown C; Carroll LM; et al. (Diabetes research and clinical practice, 2026)